SMARCB1 and neoplasm: Decreased INI-1 expression has also been observed in more than 80% of SS cases in two previous studies, in comparison with the complete loss of expression in INI-1-deficient neoplasm mimics, such as epithelioid sarcoma and malignant rhabdoid tumors6,7.